For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Harmony Biosciences Holdings Inc (NASDAQ: HRMY) was $33.80 for the day, down -18.53% from the previous closing price of $41.49. In other words, the price has decreased by -$18.53 from its previous closing price. On the day, 2.89 million shares were traded. HRMY stock price reached its highest trading level at $38.0 during the session, while it also had its lowest trading level at $33.5.
Ratios:
Our analysis of HRMY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.75. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.28.
On September 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $56.
On June 21, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $48.Citigroup initiated its Buy rating on June 21, 2024, with a $48 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 29 ’24 when JEFFREY G DIERKS bought 21,496 shares for $35.75 per share.
JEFFREY G DIERKS bought 14,961 shares of HRMY for $532,163 on Oct 03 ’24. On Oct 01 ’24, another insider, Dierks Jeffrey, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 400 shares for $40.19 each. As a result, the insider received 16,077 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRMY now has a Market Capitalization of 2365658624 and an Enterprise Value of 1702423808. As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.00, and their Forward P/E ratio for the next fiscal year is 10.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.83 while its Price-to-Book (P/B) ratio in mrq is 3.23. Its current Enterprise Value per Revenue stands at 2.497 whereas that against EBITDA is 8.531.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $41.61, while it has fallen to a 52-week low of $19.03. The 50-Day Moving Average of the stock is -7.28%, while the 200-Day Moving Average is calculated to be 3.07%.
Shares Statistics:
HRMY traded an average of 468.23K shares per day over the past three months and 846770 shares per day over the past ten days. A total of 56.77M shares are outstanding, with a floating share count of 30.67M. Insiders hold about 46.03% of the company’s shares, while institutions hold 65.00% stake in the company. Shares short for HRMY as of 1728950400 were 7452511 with a Short Ratio of 15.92, compared to 1726185600 on 8412386. Therefore, it implies a Short% of Shares Outstanding of 7452511 and a Short% of Float of 58.540000000000006.
